Skip to main content

TransMedics Group, Inc. (TMDX) Stock Forecast 2025 - AI Price Prediction & Analysis


TransMedics Group, Inc. (TMDX) AI Stock Price Forecast & Investment Analysis

TransMedics Group, Inc. Stock Price Chart and Technical Analysis

Loading TransMedics Group, Inc. interactive price chart and technical analysis...

TransMedics Group, Inc. (TMDX) - Comprehensive Stock Analysis & Investment Research

Deep dive into TransMedics Group, Inc.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about TransMedics Group, Inc., including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For TransMedics Group, Inc.: TransMedics Group, Inc. operates in the Industrial Applications and Services sector, establishing it as a mid-cap growth opportunity.

TransMedics Group, Inc. (Stock Symbol: TMDX) is a leading company in the Industrial Applications and Services sector , specifically operating within the Electromedical & Electrotherapeutic Apparatus industry.

The organization employs approximately 167 professionals worldwide .

The company has established itself as a growing mid-cap opportunity with strong fundamentals.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing TransMedics Group, Inc.'s revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For TransMedics Group, Inc.: With $531M in annual revenue and -147.5% net margin, the company demonstrates developing profitability.

Annual Revenue: $531 million generating a -147.5% net profit margin .

Market Capitalization: $3911 million - Classified as a mid-cap growth stock with balanced risk-reward profile.

Return on Equity (ROE): -59.5% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for TransMedics Group, Inc. stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Accuracy scores show historical prediction reliability.

For TransMedics Group, Inc.: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for TransMedics Group, Inc. stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: TransMedics Group, Inc.'s competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For TransMedics Group, Inc.: Market positioning analysis based on available financial and operational metrics.

TransMedics Group, Inc. strategically competes in the highly dynamic Electromedical & Electrotherapeutic Apparatus marketplace, establishing itself as a promising mid-cap growth opportunity with strong fundamentals and expanding market share .

The company maintains a healthy 55.0% gross margin, indicating strong pricing power and operational efficiency.

TransMedics Group, Inc. (TMDX) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for TransMedics Group, Inc. stock analysis.

Loading TransMedics Group, Inc. comprehensive fundamental analysis and insider trading data...

Deep dive into TransMedics Group, Inc.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if TransMedics Group, Inc. stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For TransMedics Group, Inc.: With a P/E ratio of 54.57, the market highly values future growth prospects.

P/E Ratio 54.57x
P/B Ratio 12.29x
Market Cap $3911M
EPS $2.12
Book Value/Share $9.34
Revenue/Share $15.61
FCF/Share $-1.33
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently TransMedics Group, Inc. converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For TransMedics Group, Inc.: An ROE of -59.5% indicates room for improvement in shareholder value creation.

ROE -59.5%
ROA -34.7%
ROIC -37.3%
Gross Margin 55.0%
Operating Margin -127.5%
Net Margin -147.5%
EBT Margin -119.8%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess TransMedics Group, Inc.'s ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For TransMedics Group, Inc.: A current ratio of 5.22 indicates strong liquidity.

Current Ratio 5.22x
Quick Ratio 4.13x
D/E Ratio 0.73x
Financial Leverage 2.07x
Interest Coverage -11.1x
Working Capital $135M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal TransMedics Group, Inc.'s ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For TransMedics Group, Inc.: Free cash flow of $-45M indicates cash challenges that need attention.

Operating Cash Flow $-40M
Free Cash Flow $-45M
Capital Spending $-5M
FCF/Sales -116.1%
CapEx/Sales 14.0%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively TransMedics Group, Inc. uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For TransMedics Group, Inc.: An asset turnover of 0.29x suggests room for improvement in asset utilization.

Asset Turnover 0.29x
Receivables Turnover 4.1x
Inventory Turnover 0.8x
Fixed Assets Turnover 3.5x
Days Sales Outstanding 89 days
Days Inventory 490 days
Payables Period 72 days
Cash Conversion Cycle 506 days
Understanding Financial Statement Data

What these metrics mean: Key figures from TransMedics Group, Inc.'s income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For TransMedics Group, Inc.: With annual revenue of $531M, TransMedics Group, Inc. demonstrates solid business size.

Income Statement ($ Millions)
Total Revenue $531M
Operating Income $-23M
Net Income $-27M
R&D Expense $16M
SG&A Expense $116M
Cost of Goods Sold $3M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 85%
Cash & Short-term Investments 58%
Total Liabilities 52%
Short-term Debt 5%
Accounts Receivable 9%
Inventory 13%
Dividend & Shareholder Information
Shares Outstanding 34M
Growth Metrics (YoY)
EPS Growth -0.5%

Latest TransMedics Group, Inc. Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting TransMedics Group, Inc. (TMDX) stock price and investment outlook.

TransMedics Group, Inc. Competitors & Peer Analysis - Industrial Applications and Services Sector

Comparative analysis of TransMedics Group, Inc. against industry peers and competitors in the Industrial Applications and Services sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
AXGN Unlock Forecast - 30 Days FREE Trial $759M -41.7x 6.8x
CBLL Unlock Forecast - 30 Days FREE Trial $465M x 2.7x
CNMD Unlock Forecast - 30 Days FREE Trial $1398M 12.7x 1.4x
CV Unlock Forecast - 30 Days FREE Trial $12M x x
ECOR Unlock Forecast - 30 Days FREE Trial $37M -7.3x 32.9x
EDAP Unlock Forecast - 30 Days FREE Trial $84M x 2.1x
ELMD Unlock Forecast - 30 Days FREE Trial $203M 26.9x 4.7x
FONR Unlock Forecast - 30 Days FREE Trial $103M 9.9x 0.7x
GTHP Unlock Forecast - 30 Days FREE Trial $18M x x
INMD Unlock Forecast - 30 Days FREE Trial $1055M x 1.5x
IRIX Unlock Forecast - 30 Days FREE Trial $17M -2.8x 2.9x
IRME Unlock Forecast - 30 Days FREE Trial $2M x x
ITGR Unlock Forecast - 30 Days FREE Trial $3613M 43.7x 2.1x
LIVN Unlock Forecast - 30 Days FREE Trial $2938M -662.0x 2.6x
MASI Unlock Forecast - 30 Days FREE Trial $7994M 128.1x 7.7x
MDT Unlock Forecast - 30 Days FREE Trial $122777M 26.4x 2.6x
NRXS Unlock Forecast - 30 Days FREE Trial $30M -0.9x 7.0x
NXL Unlock Forecast - 30 Days FREE Trial $26M -4.7x 4.4x
OM Unlock Forecast - 30 Days FREE Trial $235M -0.4x 1.5x
SMLR Unlock Forecast - 30 Days FREE Trial $317M 8.6x 0.8x
STRR Unlock Forecast - 30 Days FREE Trial $35M -1.6x 0.6x
STRRP Unlock Forecast - 30 Days FREE Trial $31M -5.5x 0.5x
STXS Unlock Forecast - 30 Days FREE Trial $263M -8.4x 180.4x
TIVC Unlock Forecast - 30 Days FREE Trial $3M 0.0x 0.8x
TMDX Unlock Forecast - 30 Days FREE Trial $3911M 54.6x 12.3x
VASO Unlock Forecast - 30 Days FREE Trial $21M 20.1x 0.8x
ZYXI Unlock Forecast - 30 Days FREE Trial $40M 41.4x 32.0x

Frequently Asked Questions - TransMedics Group, Inc. Stock Forecast

How accurate are TransMedics Group, Inc. stock predictions?

Our AI model demonstrates 73% historical accuracy for TMDX predictions, based on advanced machine learning algorithms trained on over 10 years of market data.

What factors influence TransMedics Group, Inc. stock price forecasts?

Our analysis considers TransMedics Group, Inc.'s financial metrics, Industrial Applications and Services sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is TransMedics Group, Inc. a good investment in 2025?

Based on our AI analysis, TransMedics Group, Inc. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are TransMedics Group, Inc. forecasts updated?

TransMedics Group, Inc. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced TransMedics Group, Inc. Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for TransMedics Group, Inc. stock.

My Portfolio

Investment Dashboard

Loading your portfolio...